BBIO R&D Expenses
Bridgebio Pharma Inc · R&D Expenses
BBIO R&D Expenses
Latest reported$530.96Mperiod ending
BBIO R&D Expenses ($30.56M → $530.96M)
Annual R&D Expenses
High-resolution chart · PNG
BBIO r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 477,536,000 | |
| 506,461,000 | |
| 455,711,000 | |
| 399,462,000 | |
| 451,024,000 | |
| 337,047,000 | |
| 209,947,000 | |
| 140,073,000 | |
| 30,556,000 |